|
|
|
Volumn 9, Issue 6, 2006, Pages 394-397
|
|
Antibacterial Drug Discovery & Development - SRI's 11th Annual Summit. Antibacterial trends and current research. 10-11 April 2006, Princeton, NJ, USA
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIBIOTIC AGENT;
AZTREONAM;
CARBAPENEM;
COLISTIN;
DALBAVANCIN;
EXTENDED SPECTRUM BETA LACTAMASE;
ICLAPRIM;
IMIPENEM;
LINEZOLID;
METICILLIN;
METRONIDAZOLE;
MINOCYCLINE;
MK 2764;
NZ 2098;
PENICILLIN G;
PLECTASIN;
POLYMYXIN B;
POLYPEPTIDE ANTIBIOTIC AGENT;
PTK 0796;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
SULFONAMIDE;
TETRACYCLINE DERIVATIVE;
TRIMETHOPRIM;
UNCLASSIFIED DRUG;
VANCOMYCIN;
ACINETOBACTER;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC SENSITIVITY;
ASPERGILLUS;
BACTERIAL INFECTION;
BACTERICIDAL ACTIVITY;
CATHETER INFECTION;
CLINICAL TRIAL;
CLOSTRIDIUM DIFFICILE;
CONFERENCE PAPER;
DRUG ANTAGONISM;
DRUG BIOAVAILABILITY;
DRUG EXCRETION;
DRUG HALF LIFE;
DRUG POTENTIATION;
DRUG PROTEIN BINDING;
DRUG RESEARCH;
DRUG STRUCTURE;
ENTEROCOCCUS FAECALIS;
ESCHERICHIA COLI;
GRAM NEGATIVE BACTERIUM;
GRAM POSITIVE BACTERIUM;
HUMAN;
KLEBSIELLA;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
MICROBIOLOGICAL EXAMINATION;
MINIMUM INHIBITORY CONCENTRATION;
MOUSE;
MULTIDRUG RESISTANCE;
MYCOBACTERIUM TUBERCULOSIS;
NONHUMAN;
RAT;
SKIN INFECTION;
SOFT TISSUE INFECTION;
STAPHYLOCOCCUS;
STAPHYLOCOCCUS AUREUS;
STREPTOCOCCUS;
STREPTOCOCCUS PNEUMONIAE;
TUBERCULOSIS;
UNSPECIFIED SIDE EFFECT;
ADMINISTRATION, ORAL;
ANIMALS;
ANTI-BACTERIAL AGENTS;
BACTERIAL INFECTIONS;
CLINICAL TRIALS;
CLINICAL TRIALS AS TOPIC;
DRUG DESIGN;
DRUG RESISTANCE, BACTERIAL;
HUMANS;
INFUSIONS, INTRAVENOUS;
MOLECULAR STRUCTURE;
PEPTIDES;
PYRIMIDINES;
RECOMBINANT PROTEINS;
TEICOPLANIN;
|
|
EID: 33744989433
PISSN: 13697056
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (4)
|
|
References (0)
|
